Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Aimei Health Technology Co., Ltd Ordinary Share(AFJK)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AFJK
09/25/2026: AFJK (1-star) is currently NOT-A-BUY. Pass it for now.
Aimei Health Technology is a specialized provider in the medical aesthetic and wellness services sector. The company primarily generates revenue through clinical procedures and digital health management, positioning itself in a growing market driven by consumer wellness trends. While the firm has demonstrated success in service scaling, it faces significant risks related to localized market concentration, regulatory oversight, and competition from much larger, well-capitalized healthcare networks. Investors should view this as a growth-oriented, higher-risk equity that lacks dividend income. Key developments to monitor include future expansion efforts, the ability to maintain service margins, and any shifts in the healthcare regulatory landscape.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company shows potential for growth in the niche medical aesthetic sector but faces scalability and competitive hurdles. |
| Momentum investor | Weak fit | Lack of consistent market volatility signals makes this a less primary target for momentum-based strategies. |
| Value investor | Mixed fit | Valuation depends heavily on future service expansion and the ability to maintain margins in a competitive industry. |
| Dividend investor | Weak fit | The company currently prioritizes reinvestment over shareholder dividends. |
| Low-risk investor | Weak fit | The healthcare services sector, combined with company-specific operational risks, creates a higher risk profile for conservative investors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock may experience significant price swings based on healthcare sector trends and company-specific news. |
| Valuation risk | Medium / high | Future earnings visibility remains uncertain, impacting current valuation models. |
| Competition risk (Healthcare service providers) | High | Competition from larger, more established medical networks could pressure margins. |
| Business quality | Medium | The business model relies on maintaining high-quality service standards across multiple locations. |
| Dividend income | Low / none | No current dividend income makes this unsuitable for income-focused portfolios. |
| Execution risk | Medium / high | Success depends on the effective management and scaling of medical service operations. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -41.62% | Avg. Invested days 116 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/25/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 38.58M USD | Price to earnings Ratio 174.07 | 1Y Target Price - |
Price to earnings Ratio 174.07 | 1Y Target Price - | ||
Volume (30-day avg) 23.6K shares | Beta 0.85 | 52 Weeks Range 6.75 - 130.37 | Updated Date 09/24/2026 |
52 Weeks Range 6.75 - 130.37 | Updated Date 09/24/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.07 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medical Aesthetic Services | Direct clinical fees from procedures and consultations. | The company generates most of its revenue by providing elective medical aesthetic treatments to patients. |
| Health Management Solutions | Consulting and digital platform subscriptions for health tracking. | Revenue is also generated through ongoing health monitoring and consulting service contracts. |
Valuation
Trailing PE 174.07 | Forward PE - | Enterprise Value 40.63M | Price to Sales(TTM) - |
Enterprise Value 40.63M | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 3.17M | Shares Floating 1.44M |
Shares Outstanding 3.17M | Shares Floating 1.44M | ||
Percent Insiders 64.96 | Percent Institutions 32.02 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Aimei Health Technology Co., Ltd Ordinary Share
Exchange NASDAQ | Headquarters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.